Amyloidosis is a serious condition where abnormal proteins called amyloids accumulate in a cat’s organs, most commonly the kidneys and liver, leading to organ dysfunction and failure. This disease is rare in felines but can progress rapidly, requiring prompt veterinary intervention to manage symptoms and improve quality of life.
What Exactly is Feline Amyloidosis?
In simple terms, amyloidosis involves the misfolding of proteins that the body cannot break down properly. These insoluble fibrils deposit in tissues, disrupting normal function. In cats, the kidneys are the primary target in most cases, causing proteinuria (excess protein in urine) and eventual renal failure. Less frequently, the liver or other organs like the spleen or intestines may be involved, leading to varied clinical presentations.
The condition arises from two main forms: primary, linked to plasma cell disorders like multiple myeloma, and secondary, triggered by ongoing inflammation or infection. Secondary amyloidosis predominates in cats, often stemming from chronic issues such as infections or immune-mediated diseases.
Breeds and Genetic Risks
Certain cat breeds face higher risks due to hereditary factors. Abyssinian, Siamese, and Oriental Shorthair cats are particularly susceptible. In Siamese and related breeds, liver involvement is more common, potentially causing rupture and life-threatening hemorrhage. Familial forms in these breeds highlight the importance of genetic screening in breeding programs to reduce incidence.
- High-risk breeds: Abyssinian, Siamese, Oriental Shorthair, Devon Rex
- Common organ affected in breeds: Kidneys (most breeds), liver (Siamese/Oriental)
- Prevention tip: Avoid breeding affected lines
Recognizing the Signs: Symptoms to Watch For
Symptoms depend on the organs impacted but often mimic chronic kidney disease. Early detection hinges on owners noticing subtle changes in their cat’s behavior and appearance.
| Organ Affected | Key Symptoms |
|---|---|
| Kidneys | Increased thirst and urination, weight loss, vomiting, lethargy, poor appetite, dull coat, dehydration, mouth ulcers |
| Liver (esp. Siamese) | Jaundice, abdominal distension, pale gums, rapid breathing, collapse, sudden weakness |
| Systemic/Other | Fluid buildup (edema), diarrhea, blood clots causing hind limb paralysis or breathing issues |
Cats may show nonspecific signs like depression and weakness initially. In advanced stages, severe complications such as thromboembolism (blood clots) can occur, blocking vessels and causing sudden paresis or respiratory distress. Up to 40% of cases in related canine models (applicable to cats) involve clotting risks due to protein loss.
Underlying Causes and Triggers
Secondary amyloidosis, the prevalent type in cats, develops from prolonged inflammatory states. Common triggers include:
- Chronic infections (e.g., fungal like blastomycosis, bacterial)
- Immune-mediated diseases
- Cancers such as plasma cell tumors or multiple myeloma
- Other systemic inflammations
Primary forms are rarer, tied directly to abnormal antibody production. Genetic predispositions amplify risks in susceptible breeds, where even without overt inflammation, amyloids form.
Notably, amyloidosis is not contagious and cannot spread between cats.
How Veterinarians Diagnose Amyloidosis
Diagnosis starts with a thorough history and physical exam. Vets look for small, irregular kidneys via palpation or ultrasound. Key tests include:
- Bloodwork: Elevated creatinine/BUN for kidney failure, low albumin from protein loss
- Urinalysis: Proteinuria, confirming renal involvement
- Imaging: Ultrasound to assess kidney/liver size and structure
- Biopsy: Gold standard—tissue sample stained with Congo red to confirm amyloid deposits
Additional checks for hypertension, clotting risks, or underlying infections guide comprehensive evaluation. Early biopsy is crucial as the disease is often advanced by symptom onset.
Treatment Strategies: Supportive Care Focus
No cure exists to dissolve amyloid deposits, so management targets underlying causes, symptom relief, and organ support. Hospitalization is often needed for dehydrated or failing cats.
- Fluid Therapy: IV fluids for 72+ hours to flush kidneys and correct dehydration
- Nutrition: Renal diets low in protein/phosphorus; feeding tubes if anorexia persists
- Medications: Renoprotectants (e.g., ACE inhibitors), antihypertensives, anticoagulants (e.g., clopidogrel) to prevent clots
- Underlying Issue Control: Antibiotics for infections, chemotherapy for cancers
- Experimental: Colchicine or DMSO in some cases, though evidence is limited in cats
Regular monitoring via bloodwork and check-ups is essential. Blood pressure control prevents further damage.
Prognosis and Long-Term Outlook
Prognosis is guarded to poor, with many cats surviving less than a year post-diagnosis, especially with kidney failure. Success improves if an underlying trigger like infection is treatable. Liver cases in predisposed breeds carry grave risks due to rupture potential. Quality of life can be maintained with diligent care, but progression is typical.
Factors influencing survival:
- Early detection
- Organ involvement (kidney better than multi-organ)
- Response to supportive therapy
Prevention and Home Management Tips
Prevent inherited forms by not breeding affected cats. Routine vet visits catch early renal changes via urinalysis. At home:
- Monitor water intake and litter box use
- Provide prescription diets
- Watch for clotting signs (e.g., dragging legs)
- Maintain flea/tick prevention to avoid secondary inflammation
Annual bloodwork for at-risk breeds aids proactive care.
Frequently Asked Questions (FAQs)
Is amyloidosis common in cats?
No, it’s rare, but more prevalent in specific breeds like Siamese.
Can my cat recover from amyloidosis?
Full recovery is unlikely; management slows progression.
What breeds are most at risk?
Abyssinian, Siamese, Oriental Shorthair.
Does amyloidosis cause pain?
Indirectly via organ failure; pain meds may be needed.
Is surgery an option?
No, it’s medical management only.
Recent Advances and Research Insights
Ongoing studies explore amyloid breakdown agents like DMSO, with preliminary hints in veterinary podcasts and trials. Peer-reviewed work emphasizes biopsy confirmation and breed-specific patterns. As of 2026, focus remains supportive, but genetic therapies hold future promise.
References
- Protein Deposits (Amyloidosis) in Cats – Causes, Treatment — Vetster. 2023. https://vetster.com/en/conditions/cat/protein-deposits-amyloidosis
- Amyloidosis in Cats — PetMD. 2024-10-15. https://www.petmd.com/cat/conditions/systemic/amyloidosis-cats
- Amyloidosis — Apple Valley Animal Hospital. 2022. https://www.applevalley.vet/sites/site-4271/documents/Amyloidosis.pdf
- A Concise Review of Amyloidosis in Animals — PMC (NCBI). 2012-04-11. https://pmc.ncbi.nlm.nih.gov/articles/PMC3329740/
- Amyloidosis in Cats — VCA Animal Hospitals. 2024. https://vcahospitals.com/know-your-pet/amyloidosis-in-cats



